Date: 26 September 2023, Tuesday
Time: 2pm - 3pm
Venue: MD6 Smart Classroom, Level 4, NUS
Presenter: Dr Alka Chaubey,
Chief Medical Officer, Bionano Genomics, Inc.
Brief synopsis:
OGM allows scientists the ability to discover chromosomal
aberrations or structural variations (SVs), a hallmark of cancer, in a way
unmatched by traditional cytogenetic techniques. In this seminar, Dr. Alka
Chaubey will discuss global users and their experience implementing OGM, key
applications, and potential implications for future clinical research and
medical guidelines.